1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow SEphB4-HSA: new trials by email Literature Review of SEphB4-HSA trials Research Report on SEphB4-HSA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors SEphB4-HSA, Pembrolizumab, Gemcitabine - Muscle-Invasive Bladder Carcinoma, Metastatic Urothelial Carcinoma | Phase 2 / Phase 3 | Recruiting | Vasgene Therapeutics, Inc | 700 | 2025-03-15 | 2025-04-03 |
Carcinoma, Transitional Cell (1)
United States (1)